These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

408 related items for PubMed ID: 11934867

  • 1. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis.
    Kalev-Zylinska ML, Horsfield JA, Flores MV, Postlethwait JH, Vitas MR, Baas AM, Crosier PS, Crosier KE.
    Development; 2002 Apr; 129(8):2015-30. PubMed ID: 11934867
    [Abstract] [Full Text] [Related]

  • 2. Pathways in blood and vessel development revealed through zebrafish genetics.
    Crosier PS, Kalev-Zylinska ML, Hall CJ, Flores MV, Horsfield JA, Crosier KE.
    Int J Dev Biol; 2002 Apr; 46(4):493-502. PubMed ID: 12141436
    [Abstract] [Full Text] [Related]

  • 3. Zebrafish scl functions independently in hematopoietic and endothelial development.
    Dooley KA, Davidson AJ, Zon LI.
    Dev Biol; 2005 Jan 15; 277(2):522-36. PubMed ID: 15617691
    [Abstract] [Full Text] [Related]

  • 4. Core-binding factor beta (CBFbeta), but not CBFbeta-smooth muscle myosin heavy chain, rescues definitive hematopoiesis in CBFbeta-deficient embryonic stem cells.
    Miller JD, Stacy T, Liu PP, Speck NA.
    Blood; 2001 Apr 15; 97(8):2248-56. PubMed ID: 11290585
    [Abstract] [Full Text] [Related]

  • 5. Zebrafish homolog of the leukemia gene CBFB: its expression during embryogenesis and its relationship to scl and gata-1 in hematopoiesis.
    Blake T, Adya N, Kim CH, Oates AC, Zon L, Chitnis A, Weinstein BM, Liu PP.
    Blood; 2000 Dec 15; 96(13):4178-84. PubMed ID: 11110689
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. RUNX1 and RUNX1-ETO: roles in hematopoiesis and leukemogenesis.
    Lam K, Zhang DE.
    Front Biosci (Landmark Ed); 2012 Jan 01; 17(3):1120-39. PubMed ID: 22201794
    [Abstract] [Full Text] [Related]

  • 12. RUNX1-Evi-1 fusion gene inhibited differentiation and apoptosis in myelopoiesis: an in vivo study.
    Shen L, Zhu J, Chen F, Lin W, Cai J, Zhong J, Zhong H.
    BMC Cancer; 2015 Dec 16; 15():970. PubMed ID: 26674644
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors.
    Okuda T, Cai Z, Yang S, Lenny N, Lyu CJ, van Deursen JM, Harada H, Downing JR.
    Blood; 1998 May 01; 91(9):3134-43. PubMed ID: 9558367
    [Abstract] [Full Text] [Related]

  • 17. The role of a Runt domain transcription factor AML1/RUNX1 in leukemogenesis and its clinical implications.
    Asou N.
    Crit Rev Oncol Hematol; 2003 Feb 01; 45(2):129-50. PubMed ID: 12604126
    [Abstract] [Full Text] [Related]

  • 18. Runx1 is essential for hematopoietic commitment at the hemangioblast stage of development in vitro.
    Lacaud G, Gore L, Kennedy M, Kouskoff V, Kingsley P, Hogan C, Carlsson L, Speck N, Palis J, Keller G.
    Blood; 2002 Jul 15; 100(2):458-66. PubMed ID: 12091336
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.